<?xml version="1.0" encoding="UTF-8"?>
<ref id="B36" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Weng</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Qi</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lu</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wang</surname>
    <given-names class="given-names">K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Tian</surname>
    <given-names class="given-names">Z.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hu</surname>
    <given-names class="given-names">K.</given-names>
   </name>
   <etal class="etal"/>
  </person-group> (
  <year class="year">2014</year>). 
  <article-title class="article-title">The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations.</article-title>
  <source class="source">
   <italic class="italic">J. Nanobiotechnol.</italic>
  </source>
  <volume class="volume">12</volume>:
  <issue class="issue">39</issue>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1186/s12951-014-0039-3</pub-id>
  <?supplied-pmid 25248304?>
  <pub-id pub-id-type="pmid" class="pub-id">25248304</pub-id>
 </mixed-citation>
</ref>
